Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending March 1, 2015
Hospital Readmission After Cancer Surgery, 5 Factors linked to high rate of returning patients
Male Pattern Baldness and Prostate Cancer, Is there a pathophysiologic connection?
Reducing Renal Cell Carcinoma Risk, Micronutrient linked to 39% risk reduction
Are Breast Density Laws Effective? , A review from a 1960 birth cohort
FDA Expands Use of Imbrutinib , Now approved for Waldenström Macroglobulinemia
Must reads for theWeek ending February 15, 2015
Is Primary Tumor Resection Overused in Colorectal Cancer Patients? , Research shows the majority of stage IV patients undergo procedure
Report Highlights Need for Update to Atypical Hyperplasia of Breast Guides, Recommendations for diagnosis, risks of breast cancer, and prevention
Who Benefits From Tamoxofin Plus Ovarian Suppression? , Chemotherapy history key in 5-year impact of estrogen blocking
Is Targeted Biopsy Better for Detecting Prostate Cancer?, Study highlights benefits of standard versus MRI biopsies
Guideline Update: VTE Prophylaxis and Treatment in Oncology, What to use for venous thromboembolism in cancer patients